Astrocyte modulation of in vitro β-amyloid neurotoxicity

GLIA

Volumn 46, Issue 3, 2004, Pages 252-260

  Paradisi, Silvia ^a   Sacchetti, Benedetto ^a   Balduzzi, Maria ^a   Gaudi, Simona ^a   Malchiodi Albedi, Fiorella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

amyloid; Alzheimer's disease; Apoptosis; Astrocytes; Cocultures; Hippocampal neurons; Neuritic dysplasia; Neurotoxicity; Synaptic loss

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOLOCALIZATION; NERVE CELL CULTURE; NERVE GROWTH; NEUROPATHY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; PHYSIOLOGY; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; CELLS, CULTURED; HIPPOCAMPUS; RATS; RATS, WISTAR;

EID: 2442707942     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20005     Document Type: Article

References (33)

1. Caceres J, Brandan E. 1997. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans. J Cell Biochem 65:145-158.
2. Canning DR, McKeon RJ, DeWitt DA, Perry G, Wujek JR, Frederickson RCA, Silver J. 1993. β-amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 124:289-298.
3. Canning DR, Hoke A, Malemud CJ, Silver J. 1996. A potent inhibitor of neurite outgrowth that predominates in the extracellular matrix of reactive astrocytes. Int J Dev Neurosci 14:153-175.
4. Cardoso SM, Oliveira CR. 2003. Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic Res 37:241-250.
5. Casley CS, Land JM, Sharpe MA, Clark JB, Duchen MR, Canevari L. 2002. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis 10:258-267.
6. DeKosky ST, Scheff SW. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464.
7. DeWitt DA, Silver J. 1996. Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's disease. Exp Neurol 142:103-110.
8. Domenici MR, Paradisi S, Sacchetti B, Gaudi S, Balduzzi M, Bernardo A, Ajmone-Cat MA, Minghetti L, Malchiodi-Albedi F. 2002. The presence of astrocytes enhances beta amyloid-induced neurotoxicity in hippocampal cell cultures. J Physiol (Paris) 96:313-316.
9. Dowson VL. 1995. Nitric Oxide: role in neurotoxicity. Clin Exp Pharmacol Physiol 22:305-308.
10. Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
11. Forloni G, Chiesa R, Smiroldo S, Versa S, Salmona M, Tagliavini F, Angeretti N. 1993. Apoptosis mediated neurotoxicity induced by chronic application of beta-amyloid fragment 25-35. Neuroreport 4:523-526.
12. Goslin K, Banker GA. 1991. Rat hippocampal neurons in low-density culture. In: Banker GA, Goslin K, editors. Culturing nerve cells. Cambridge: MIT Press. p 251-281.
13. Grace EA, Busciglio J. 2002. Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 23:493-502.
14. Grace EA, Rabiner CA, Busciglio J. 2002. Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience 114:265-273.
15. Griffin WST, Sheng GJ, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE. 1998. Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression. Brain Pathol 8:65-72.
16. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. 1998. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res 785:195-206.
17. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. 1991. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
18. Lorenzo A, Yankner BA. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91:12243-12247.
19. Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B, Yankner BA. 2000. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci 3:460-464.
20. Malchiodi-Albedi F, Domenici MR, Paradisi S, Bernardo A, Ajmone-Cat MA, Minghetti L. 2001. Astrocytes contribute to neuronal impairment in beta A toxicity increasing apoptosis in rat hippocampal neurons. Glia 34:68-72.
21. Masliah E. 2001. Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders. J Alzheimers Dis. 3:121-129.
22. McKee AC, Kosik KS, Kowall NW. 1991. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol. 30:156-165.
23. Meske U, Hamker U, Albert F, Ohm TG. 1998. The effects of β/A4 and its fragments on calcium homeostasis, glial fibrillary acidic protein and S100β staining, morphology and survival of cultured hippocampal astrocytes. Neuroscience 85:1151-1160.
24. Peña LA, Brecher CW, Marshak DR. 1995. β-amyloid regulates gene expression of glial trophic substances S-100β in C6 glioma and primary astrocyte cultures. Mol Brain Res 34:118-126.
25. Peuchen S, Balanos JP, Heales SJ, Almeida A, Duchen MR, Clark JB. 1997. Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. Prog Neurobiol 52:261-281.
26. Pike CJ, Cummings BJ, Cotman CW. 1992. beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport. 3:769-72.
27. Pike CJ, Cummings R, Monzavi R, Cotman CW. 1994. β-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63:517-531.
28. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. 2002. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40:260-269.
29. Rohn TT, Rissman RA, Head E, Cotman CW. 2002. Caspase activation in the Alzheimer's disease brain: tortuous and torturous. Drug News Perspect 15:549-557.
30. Sabo S, Lambert MP, Kessey K, Wade W, Krafft G, Klein WL. 1995. Interaction of beta-amyloid peptides with integrins in a human nerve cell line. Neurosci Lett 184:25-28.
31. Terry RD, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R, Hansen L, Katzman R. 1990. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
32. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. 2001. Control of synapse number by glia. Science 291:569-570.
33. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457.